Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. Among authors: ascierto pa. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection.
Quarto G, Benassai G, Colao A, Cittadini A, Ascierto PA, Pivonello R, Elefante A, Bocchino M, Marra AM, Gentile I, Benassai G, Miletti A, Calemma F, Furino E; members of FACTA study group. Quarto G, et al. Among authors: ascierto pa. J Transl Med. 2024 Jan 17;22(1):70. doi: 10.1186/s12967-024-04857-w. J Transl Med. 2024. PMID: 38233934 Free PMC article.
Cost of illness del carcinoma cutaneo a cellule squamose (CSCC).
Marcellusi A, Bini C, Peris K, Ascierto PA, Mennini FS. Marcellusi A, et al. Among authors: ascierto pa. Glob Reg Health Technol Assess. 2020 Dec 28;7:148-153. doi: 10.33393/grhta.2020.2171. eCollection 2020 Jan-Dec. Glob Reg Health Technol Assess. 2020. PMID: 36627959 Free PMC article. Italian.
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for.
Parola S, Oing C, Rescigno P, Feliciano S, Carlino F, Pompella L, Marretta AL, De Santo I, Viggiani M, Muratore M, Facchini BA, Orefice J, Cioli E, Sparano F, Mallardo D, De Giorgi U, Palmieri G, Ascierto PA, Ottaviano M. Parola S, et al. Among authors: ascierto pa. Front Genet. 2024 Nov 29;15:1480417. doi: 10.3389/fgene.2024.1480417. eCollection 2024. Front Genet. 2024. PMID: 39678373 Free PMC article. Review.
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology.
Quagliariello V, Passariello M, Bisceglia I, Paccone A, Inno A, Maurea C, Rapuano Lembo R, Manna L, Iovine M, Canale ML, Scherillo M, Ascierto PA, Gabrielli D, De Lorenzo C, Maurea N. Quagliariello V, et al. Among authors: ascierto pa. Front Cardiovasc Med. 2024 Jan 23;11:1232269. doi: 10.3389/fcvm.2024.1232269. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38322766 Free PMC article.
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology.
Kandolf L, Ascierto PA, Bastholt L, Gavrilova I, Haanen J, Hauschild A, Herceg D, Hoeller C, Jalovcic Suljevic A, Kessels JI, Krajsova I, Kukushkina M, Lallas A, Lorigan P, Mangana J, Marquez-Rodas I, Mazilu L, Mohr P, Bylaite-Bucinskiene M, Ocvirk J, Olah J, Putnik K, Rutkowski P, Saiag P, Samolyenko I, Schwarze JK, Stojkovski I, Cicmil Sarić N, Vieira R, Weichenthal M, Garbe C. Kandolf L, et al. Among authors: ascierto pa. Eur J Cancer. 2024 Nov 16;216:115124. doi: 10.1016/j.ejca.2024.115124. Online ahead of print. Eur J Cancer. 2024. PMID: 39721295
Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047.
Tawbi HA, Hodi FS, Lipson EJ, Schadendorf D, Ascierto PA, Matamala L, Castillo Gutiérrez E, Rutkowski P, Gogas H, Lao CD, Janoski De Menezes J, Dalle S, Arance AM, Grob JJ, Ratto B, Rodriguez S, Mazzei A, Dolfi S, Long GV. Tawbi HA, et al. Among authors: ascierto pa. J Clin Oncol. 2024 Dec 13:JCO2401124. doi: 10.1200/JCO.24.01124. Online ahead of print. J Clin Oncol. 2024. PMID: 39671533
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma.
Handel EE, McKeown J, Wei J, Kankaria RA, Burnette H, Johnson DB, Lawless A, Czapla J, Sullivan RJ, Albrecht LJ, Zimmer L, Mangana J, Dummer R, Kessels JI, Neyns B, Allayous C, Lebbe C, Boatwright C, Mehnert JM, Ottaviano M, Ascierto PA, Czarnecka AM, Rutkowski P, Lo SN, Long GV, Menzies AM, Carlino MS. Handel EE, et al. Among authors: ascierto pa. Eur J Cancer. 2024 Dec 9;215:115171. doi: 10.1016/j.ejca.2024.115171. Online ahead of print. Eur J Cancer. 2024. PMID: 39667250
689 results